Soulillou, J P <br/><br/>
Prevention of rejection of kidney transplants by monoclonal antibody directed against interleukin 2.  [electronic resource] 

 -  Lancet (London, England)  Jun 1987 
 - 1339-42 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0140-6736 
<br/><br/><label>Standard No.: </label>10.1016/s0140-6736(87)90648-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adolescent<br/>Adult<br/>Antibodies, Monoclonal--therapeutic use<br/>Antilymphocyte Serum--therapeutic use<br/>Child<br/>Evaluation Studies as Topic<br/>Female<br/>Graft Rejection<br/>Humans<br/>Interleukin-2--immunology<br/>Kidney Transplantation<br/>Lymphocyte Activation<br/>Male<br/>Middle Aged<br/>Receptors, Immunologic--immunology<br/>Receptors, Interleukin-2<br/>T-Lymphocytes--immunology<br/>Time Factors